Interoperability Platforms 2019
Shifting Away from Traditional HIE

Author
Coray Tate

October 17, 2019 | Read Time: 3 minutes

Interest in HIE technology exploded nearly a decade ago, and the HIE solution market has been in flux ever since. Today, the field of vendors is narrow, and many provider organizations want technology that is more than a conduit for sharing patient records—they are looking for interoperability platforms that enable the use of aggregated data for innovative use cases. To understand where vendors are in the transition from traditional HIE to interoperability platforms, KLAS interviewed organizations identified by their vendor as their most advanced users. In-depth interviews with these organizations—as well as general performance feedback from vendors’ broader customer bases—reveal wide variation in use cases and the customer experience.

to see the full dataset.

if you don't have a login, getting started is easy.

Provider Organizations

Fill out our registration form to verify your organization.

Provider Registration

HIT Companies

Contact a KLAS representative for plans and pricing.

Contact KLAS

Key Findings

InterSystems and Allscripts Customers Most Likely to Report Advanced Use Cases
Advanced Sites May Not Represent the Typical Experience
No Shortcuts for Implementation; InterSystems and Health Catalyst Easiest to Maintain
Inconsistent Feature Adoption Weakens Point-of-Care Experience for Allscripts Customers; Most Orion Health Users Rely on Portal
InterSystems Customer Success Leading to Highest Purchasing Energy

Writer
Elizabeth Pew

Designer
Jess Wallace-Simpson

Download Report Brief Download Full Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2021 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.